Characteristics for 3 cohorts of Danish patients diagnosed with ET, PV, or CML during 1977-2008 and followed for new primary cancers
| . | ET patients, n (%) . | PV patients, n (%) . | CML patients, n (%) . |
|---|---|---|---|
| All | 1578 (100.0) | 4625 (100.0) | 1026 (100.0) |
| Women | 1050 (66.5) | 2017 (43.6) | 446 (43.5) |
| Men | 528 (33.5) | 2608 (56.4) | 580 (56.5) |
| Age, y | |||
| 20-49 | 325 (20.6) | 717 (15.5) | 329 (32.1) |
| 50-69 | 634 (40.2) | 2190 (47.4) | 422 (41.1) |
| 70+ | 619 (39.2) | 1718 (37.1) | 275 (26.8) |
| Year of diagnosis | |||
| 1977-1994 | 233 (14.8) | 2753 (59.5) | 569 (55.5) |
| 1995-2008 | 1345 (85.2) | 1872 (40.5) | 457 (44.5) |
| Follow-up time | |||
| Year 2 | 245 (15.5) | 560 (12.1) | 256 (25.0) |
| Years 3-5 | 550 (34.9) | 1398 (30.2) | 422 (41.1) |
| Years 6+ | 783 (49.6) | 2667 (57.7) | 348 (33.9) |
| Outpatient contact only (for diagnoses made in 1995 and later) | 834 (62.0) | 1087 (58.1) | 157 (34.4) |
| Chronic obstructive pulmonary disease | 107 (7.0) | 427 (9.2) | 30 (2.9) |
| . | ET patients, n (%) . | PV patients, n (%) . | CML patients, n (%) . |
|---|---|---|---|
| All | 1578 (100.0) | 4625 (100.0) | 1026 (100.0) |
| Women | 1050 (66.5) | 2017 (43.6) | 446 (43.5) |
| Men | 528 (33.5) | 2608 (56.4) | 580 (56.5) |
| Age, y | |||
| 20-49 | 325 (20.6) | 717 (15.5) | 329 (32.1) |
| 50-69 | 634 (40.2) | 2190 (47.4) | 422 (41.1) |
| 70+ | 619 (39.2) | 1718 (37.1) | 275 (26.8) |
| Year of diagnosis | |||
| 1977-1994 | 233 (14.8) | 2753 (59.5) | 569 (55.5) |
| 1995-2008 | 1345 (85.2) | 1872 (40.5) | 457 (44.5) |
| Follow-up time | |||
| Year 2 | 245 (15.5) | 560 (12.1) | 256 (25.0) |
| Years 3-5 | 550 (34.9) | 1398 (30.2) | 422 (41.1) |
| Years 6+ | 783 (49.6) | 2667 (57.7) | 348 (33.9) |
| Outpatient contact only (for diagnoses made in 1995 and later) | 834 (62.0) | 1087 (58.1) | 157 (34.4) |
| Chronic obstructive pulmonary disease | 107 (7.0) | 427 (9.2) | 30 (2.9) |
The number of patients is shown, with percentages within in each stratum in parentheses.